ANKTIVA ® Drug Substance completed and released with two-year storage stability data sufficient for 170,000 doses of ANKTIVA product ImmunityBio’s 400,000 square foot GMP fill-finish facility in ...
In 1940, British Prime Minister Winston Churchill famously said, in relation to the Battle of Dunkirk, “Wars are not won by ...
Over 400,000 square foot, state-of-the-art, finish-fill and lyophilization facility enables one billion doses of RNA and adjuvant vaccine production Newly constructed Current Good Manufacturing ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min ImmunityBio has filed a WARN ...
As it continues construction, ImmunityBio noted in a quarterly regulatory filing that it believes governmental funding will assist in funding a portion of the further build-out in Dunkirk. As of March ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The Los Angeles-based company is far different from Athenex ...
DUNKIRK, N.Y. (WKBW) — Layoffs are coming for nearly 40 employees at ImmunityBio, a late-clinical-stage immunotherapy company in Dunkirk. According to a WARN notice filed on September 29, the facility ...
DUNKIRK, N.Y. (WKBW) — Athenex, a global biopharmaceutical company, has entered into an agreement for ImmunityBio to assume its lease of a manufacturing facility in Dunkirk and certain related assets.
As it continues construction, ImmunityBio noted in a quarterly regulatory filing that it believes governmental funding will assist in funding a portion of the further build-out in Dunkirk. As of March ...
DUNKIRK, N.Y. — ImmunityBio has filed a WARN notice with the New York state Department of Labor for two layoffs at its plant in Dunkirk. According to the notice, the California-based biopharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results